Alon, Assaf http://orcid.org/0000-0001-8102-5290
Lyu, Jiankun http://orcid.org/0000-0002-0461-5454
Braz, Joao M. http://orcid.org/0000-0001-8955-0735
Tummino, Tia A. http://orcid.org/0000-0001-9155-820X
Craik, Veronica http://orcid.org/0000-0001-5463-1199
O’Meara, Matthew J. http://orcid.org/0000-0002-3128-5331
Webb, Chase M.
Radchenko, Dmytro S. http://orcid.org/0000-0001-5444-7754
Moroz, Yurii S. http://orcid.org/0000-0001-6073-002X
Huang, Xi-Ping
Liu, Yongfeng http://orcid.org/0000-0002-8649-7892
Roth, Bryan L. http://orcid.org/0000-0002-0561-6520
Irwin, John J.
Basbaum, Allan I. http://orcid.org/0000-0002-1710-6333
Shoichet, Brian K. http://orcid.org/0000-0002-6098-7367
Kruse, Andrew C. http://orcid.org/0000-0002-1467-1222
Article History
Received: 20 April 2021
Accepted: 19 October 2021
First Online: 8 December 2021
Competing interests
: A.C.K. is a founder and consultant for biotechnology companies Tectonic Therapeutic and Seismic Therapeutic, as well as the Institute for Protein Innovation, a non-profit research institute. B.K.S. is a founder of Epiodyne, a company active in analgesia, and of Blue Dolphin, which undertakes fee-for-service ligand-discovery.